0001628280-24-008959.txt : 20240305
0001628280-24-008959.hdr.sgml : 20240305
20240305164440
ACCESSION NUMBER: 0001628280-24-008959
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Akinsanya Karen
CENTRAL INDEX KEY: 0001797672
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 24721509
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
wk-form4_1709675058.xml
FORM 4
X0508
4
2024-03-04
0
0001490978
Schrodinger, Inc.
SDGR
0001797672
Akinsanya Karen
C/O SCHRODINGER, INC.,
1540 BROADWAY, 24TH FLOOR
NEW YORK
NY
10036
0
1
0
0
President of R&D, Therapeutics
0
Stock Option (right to buy)
25.24
2024-03-04
4
A
0
120000
0
A
2034-03-04
Common Stock
120000
120000
D
The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.
/s/ Donald Shum, as attorney-in-fact for Karen Akinsanya
2024-03-05